Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study
This modified Delphi process provided consensus statements on the identification of ILD progression that were supported by a broad group of clinicians and may help to inform clinical practice until robust evidence-based guidelines are available.
Authors
- Sara Tomassetti (ORCID: https://orcid.org/0000-0002-4781-6539)
- Kevin R. Flaherty (ORCID: https://orcid.org/0000-0001-7686-0291)
- Vincent Cottin (ORCID: https://orcid.org/0000-0002-5591-0955)
- Simon Walsh (ORCID: https://orcid.org/0000-0003-0497-5297)
- Elizabeth R. Volkmann (ORCID: https://orcid.org/0000-0003-3750-6569)
- Yasuhiro Kondoh (ORCID: https://orcid.org/0000-0001-7456-5459)
- Anand Devaraj
- Kevin K. Brown (ORCID: https://orcid.org/0000-0002-9209-3261)
- Peter Myles George (ORCID: https://orcid.org/0000-0003-1316-4891)
- Kerri A. Johannson (ORCID: https://orcid.org/0000-0003-1205-5511)
- Ayodeji Adegunsoye (ORCID: https://orcid.org/0000-0002-7015-9610)
- Sonye K. Danoff (ORCID: https://orcid.org/0000-0001-9172-8977)
- Athol U. Wells (ORCID: https://orcid.org/0000-0003-2108-6248)
- Martin Kolb (ORCID: https://orcid.org/0000-0003-3837-1467)
- Andrew G. Nicholson
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Johns Hopkins University (US)
- University of Calgary (CA)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University of Michigan (US)
- Johns Hopkins Medicine (US)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- Harefield Hospital (GB)
- National Jewish Health (US)
- University of Chicago (US)
- Lung Institute (US)
- Hôpital Louis Pradel (FR)
- Tosei General Hospital (JP)
- University of Florence (IT)
- Imperial College London (GB)
- St. Joseph’s Healthcare Hamilton (CA)
- University of Colorado Denver (US)
- McMaster University (CA)
Publication Details
- Journal
- Respiratory Research
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1186/s12931-024-03070-z
- Citations
- 10
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- Bristol-Myers Squibb
- GlaxoSmithKline
- Sanofi
- Biogen
- United Therapeutics Corporation
- CSL Behring
- Taiho Pharmaceutical
- Galecto
- Nippon Shinyaku
- Kyorin Pharmaceutical
- Galápagos
- Eisai
- Shionogi
- Teijin Pharma
- Mitsubishi Tanabe Pharma Corporation
- Novartis Pharma
- Chugai Pharmaceutical